CPRXNEUTRAL

CPRX EV/EBITDA Analysis

10.1x

Higher than 18% of Healthcare sector peers

Updated 155h ago·SEC filings & market data

Key Takeaway

EV/EBITDA measures a company's total enterprise value relative to its earnings before interest, taxes, depreciation, and amortization—a 10.1x current value means investors pay about 10.1 times those earnings for CPRX.

Sector Performance

18th percentile

CPRX

10.1x

Sector Median

16.1x

Sector Avg

29.1x

Prior Period

10.1x(Jun 2026)

→ Stable

📊

Deep Analysis

That sits well below the healthcare sector median of 16.1x, at the 18th percentile among peers, so CPRX is cheaper than most comparable companies. The trend is unavailable: year-over-year change is N/A and quarter-over-quarter change is N/A, with only a single historical value of 10.1x listed. Because no trend data exists, the low multiple could indicate a value opportunity or a persistent discount that reflects underlying issues. The combination of a below-median level without any directional evidence leaves investment risk and reward uncertain. This metric supports the overall NEUTRAL verdict, as the low valuation is intriguing but lacks the confirmation a trend would provide.

Frequently Asked Questions

What does the EV/EBITDA tell investors about CPRX?

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

How is the EV/EBITDA calculated?

EV/EBITDA is calculated as: Enterprise Value / EBITDA.

How does CPRX's EV/EBITDA compare to its sector?

CPRX's EV/EBITDA of 10.1x compares to a Healthcare sector median of 16.1x, placing it in the 18th percentile.

Who are CPRX's closest peers by EV/EBITDA?

The closest Healthcare peers by EV/EBITDA include: CAH (15.2x), RVTY (17.0x), DGX (14.3x), AMGN (14.0x), ALGN (13.5x).

📚

Learn More About EV/EBITDA

EV/EBITDA Explained: The Valuation Metric Pro Investors Actually Use

Learn what EV/EBITDA is, why it beats P/E for capital-heavy companies, typical sector ranges, and key limitations every serious investor should know.

The Formula

Enterprise Value / EBITDA

Why It Matters

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.